Hyaluronidase-catalyzed copolymerization for the single-step synthesis of functionalized hyaluronan derivatives

Biomacromolecules

Volumn 8, Issue 4, 2007, Pages 1327-1332

  Ochiai, Hirofumi ^a   Ohmae, Masashi ^a   Mori, Tomonori ^a,b   Kobayashi, Shiro ^a,c  

^a KYOTO UNIVERSITY   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^c KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ANALYSIS; COPOLYMERIZATION; COPOLYMERS; DERIVATIVES; MONOMERS; SYNTHESIS (CHEMICAL);

COPOLYMERIZATION REACTIONS; FUNCTIONALIZED HYALURONAN DERIVATIVES; HYALURONIDASE-CATALYZED COPOLYMERIZATION; POLYMER CHAIN; SINGLE-STEP SYNTHESIS;

BIOPOLYMERS;

GLUCOSAMINE; HYALURONIC ACID DERIVATIVE; HYALURONIDASE; METHYL GROUP; MONOMER; OXAZOLINE DERIVATIVE; VINYL DERIVATIVE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; CONTROLLED STUDY; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; STRUCTURE ANALYSIS; SYNTHESIS;

CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; CATALYSIS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; TIME FACTORS;

EID: 34247574139     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm061136d     Document Type: Article

References (49)

1. Weissmann, B.; Meyer, K. J. Am. Chem. Soc. 1954, 76, 1753-1757.
2. Ernst, S.; Langer, R.; Cooney, C. L.; Sasisekharan, R. Crit. Rev. Biochem. Mol. Biol. 1995, 30, 387-444.
3. (a) Selleck, S. B. Trends Genet. 2000, 16, 206-212.
4. (b) Iozzo, R. V. Annu. Rev. Biochem. 1998, 67, 609-652.
5. (a) Watanabe, H.; Yamada, Y. Nat. Genet. 1999, 21, 225-229.
6. (b) Watanabe, H.; Kimata, K.; Line, S.; Strong, D.; Gao, L. Y.; Kozak, C. A.; Yamada, Y. Nat. Genet. 1994, 7, 154-157.
7. (c) Hardingham, T. E.; Muir, H. Biochim. Biophys. Acta 1972, 279, 401-405.
8. (a) Toole, B. P. Cell Dev. Biol. 2001, 12, 79-87.
9. (b) Sherman, L.; Sleeman, J.; Herrlich, P.; Ponta, H. Curr. Opin. Cell Biol. 1994, 6, 726-733.
10. (c) Toole, B. P. Proteoglycans and Hyaluronan in Morphogenesis and Differentiation. In Cell Biology of Extracellular Matrix, 2nd ed.; Hay, E., Ed.; Plenum Press: New York, 1991; 305-341.
11. (d) Toole, B. P. Glycosaminoglycans in Morphogenesis. In Cell Biology of Extracellular Matrix; Hay, E., Ed.; Plenum Press: New York, 1981; 259-294.
12. (a) Noble, P. W. Matrix Biol. 2002, 21, 25-29.
13. (b) Cichy, J.; Puré, E. J. Cell Biol. 2003, 161, 839-843.
14. (a) Zhuo, L.; Kimata, K. Cell Struct. Funct. 2001, 26, 189-196.
15. (b) Salustri, A.; Yanagishita, M.; Underhill, C. B.; Laurent, T. C.; Hascall, V. C. Dev. Biol. 1992, 151, 541-551.
16. (c) Fulop, C.; Salustri, A.; Hascall, V. C. Arch. Biochem. Biophys. 1997, 337, 261-266.
17. Evanko, S. P.; Wight, T. N. J. Histochem. Cytochem. 1999, 47, 1331-1341.
18. Tammi, R.; Rilla, K.; Pienimäki, J.-P.; MacCallum, D. K.; Hogg, M.; Luukkonen, M.; Hascall, V. C.; Tammi, M. J. Biol. Chem. 2001, 276, 35111-35122.
19. Goa, K. L.; Benfield, P. Drugs 1994, 47, 536-566.
20. (a) Balazs, E. A.; Denlinger, J. L. J. Rheumatol. 1993, 20, 3-9.
21. (b) Liesegang, T. J. Surv. Ophthalmol. 1990, 34, 268-293.
22. (c) Sintzel, M. B.; Bernatchez, S. F.; Tabatabay, C.; Gurny, R. Eur. J. Pharm. Biopharm. 1996, 42, 358-374.
23. (d) Le, Bourlais, C.; Acar, L.; Zia, H.; Sado, P. A.; Needham, T.; Leverge, R. Prog. Retin. Eye Res. 1998, 17, 33-59.
24. Obata, A.; Ikushima, K. JP Patent 91,352,118, 1993.
25. (a) Prisell, P. T.; Camber, O.; Hiselius, J.; Norstedt, G. Int. J. Pharm. 1992, 85, 51-56.
26. (b) Igari, Y.; Yamada, M.; Ogawa, Y. Eur. Patent 503,583, 1992.
27. (c) Doherty, M. M.; Hughes, P. J.; Korszniak, P. J.; Charman, W. N. Anesth. Analg. (Baltimore) 1995, 80, 740-746.
28. Fraser, J. R. E. In Fourth International Workshop on Hyaluronan in Drug Delivery; Willoughby, D., Ed.; RSM Press: London, 1996; p 2.
29. Brown, M. B.; Marriott, C.; Martin, G. P. Int. J. Tissue React. 1995, 17, 133-140.
30. Mitchell, J. D.; Lee, R.; Hodakowski, G. T.; Neya, K.; Harringer, W.; Valeri, C. R.; Vlahakes, G. J. J. Thorac. Cardiovasc. Surg. 1994, 107, 1481-1488.
31. Lin, K.; Bartlett, S. P.; Matsuo, K.; LiVolsi, V. A.; Parry, C.; Hass, B.; Whitaker, L. A. Plast. Reconstr. Surg. 1994, 94, 306-315.
32. Prestwich, G. D.; Marecak, D. M.; Marecek, J. F.; Vercruysse, K. P.; Ziebell M. R. In The Chemistry, Biology, and Medical Applications of Hyaluronan and Its Derivatives; Laurent T. C., Ed.; Portland Press: London, 1998, pp. 43-65.
33. (a) Crescenzi, V.; Francescangeli, A.; Renier, D.; Bellini, D. Biopolymers 2002, 64, 86-94.
34. (b) Oerther, S.; Maurin, A.-C.; Payan, E.; Hubert, P.; Lapicque, F.; Presle, N.; Dexheimer, J.; Netter, P.; Lapicque, F. Biopolymers 2000, 54, 273-281.
35. (c) Dahl, L. B.; Laurent, T. C.; Smedsrod, B. Anal. Biochem. 1988, 175, 397-407.
36. (d) Curvall, M.; Lindberg, B.; Lonngren, J. Carbohydr. Res. 1975, 41, 235-239.
37. (a) Kobayashi, S.; Morii, H.; Itoh, R.; Kimura, S.; Ohmae, M. J. Am. Chem. Soc. 2001, 123, 11825-11826.
38. (b) Ochiai, H.; Ohmae, M.; Mori, T.; Kobayashi, S. Biomacromolecules 2005, 6, 1068-1084.
39. (a) Kobayashi, S.; Fujikawa, S.; Ohmae, M. J. Am. Chem. Soc. 2003, 125, 14357-14369.
40. (b) Fujikawa, S.; Ohmae, M.; Kobayashi, S. Biomacromolecules 2005, 6, 2935-2942.
41. (a) Kobayashi, S.; Ohmae, M. Adv. Polym. Sci. 2006, 194, 159-210.
42. (b) Kobayashi, S.; Uyama, H.; Kimura, S. Chem. Rev. 2001, 101, 3793-3818.
43. (c) Kobayashi, S.; Uyama, H.; Ohmae, M. Bull. Chem. Soc. Jpn. 2001, 74, 613-635.
44. (d) Kobayashi, S. J. Polym. Sci., Polym. Chem. Ed. 1999, 37, 3041-3056.
45. (e) Kobayashi, S.; Shoda, S.; Uyama, H. Adv. Polym. Sci. 1995, 121, 1-30.
46. Jacobs, A.; Dahlman, O. Anal. Chem. 2001, 73, 405-410.
47. Normally, higher molecular mass polysaccharides are very difficult to analyze using the MALDI-TOF/MS method. In order to detect such polysaccharides, higher laser energy is required because then the glycosidic bonds tend to cleave. Here, the energy strength was controlled so that we could detect the sample polysaccharides with the molecular mass lower than ∼2000.
48. 20b
49. Morris, E. R.; Rees, D. A.; Welsh, E. J. J. Mol. Biol. 1980, 138, 383-400.